Effectiveness of Switching Smoking-Cessation Medications Following Relapse

American Journal of Preventive Medicine

Volumn 53, Issue 2, 2017, Pages e63-e70

  Heckman, Bryan W ^a,b   Cummings, K Michael ^a,b   Kasza, Karin A ^c   Borland, Ron ^d   Burris, Jessica L ^e,f   Fong, Geoffrey T ^g,h   McNeill, Ann ⁱ   Carpenter, Matthew J ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d CANCER EPIDEMIOLOGY CENTRE   (Australia)

^e UNIVERSITY OF KENTUCKY   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

^g UNIVERSITY OF WATERLOO   (Canada)

^h ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE; NICOTINE GUM; NICOTINE LOZENGE; NICOTINE PATCH; VARENICLINE;

ABSTINENCE; ADULT; ARTICLE; AUSTRALIA; CANADA; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PREVALENCE; PROSPECTIVE STUDY; RELAPSE; SMOKING; SMOKING CESSATION; UNITED KINGDOM; UNITED STATES; YOUNG ADULT; HEALTH SURVEY; MIDDLE AGED; PROCEDURES; RECURRENT DISEASE; SMOKING PREVENTION; STATISTICS AND NUMERICAL DATA; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

ADULT; AUSTRALIA; CANADA; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; SMOKING CESSATION; SMOKING PREVENTION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES;

EID: 85015748515     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2017.01.038     Document Type: Article

References (34)

1. U.S. DHSS. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General: Reports of the Surgeon General. 2014, U.S. DHHS, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA.
2. Joseph, A.M., Fu, S.S., Lindgren, B., et al. Chronic disease management for tobacco dependence: a randomized, controlled trial. Arch Intern Med 171:21 (2011), 1894–1900, 10.1001/archinternmed.2011.500.
3. Borland, R., Yong, H.H., Balmford, J., et al. Motivational factors predict quit attempts but not maintenance of smoking cessation: findings from the International Tobacco Control Four country project. Nicotine Tob Res 12:suppl (2010), S4–S11, 10.1093/ntr/ntq050.
4. Joseph, A.M., Rice, K., An, L.C., Mohiuddin, A., Lando, H., Recent quitters’ interest in recycling and harm reduction. Nicotine Tob Res 6:6 (2004), 1075–1077, 10.1080/14622200412331324893.
5. Hughes, J.R., Solomon, L.J., Naud, S., Fingar, J.R., Helzer, J.E., Callas, P.W., Natural history of attempts to stop smoking. Nicotine Tob Res 16:9 (2014), 1190–1198, 10.1093/ntr/ntu052.
6. Chaiton, M., Diemert, L., Cohen, J.E., et al. Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers. BMJ Open, 6(6), 2016, e011045, 10.1136/bmjopen-2016-011045.
7. Borland, R., Partos, T.R., Yong, H.H., Cummings, K.M., Hyland, A., How much unsuccessful quitting activity is going on among adult smokers? Data from the International Tobacco Control Four Country cohort survey. Addiction 107:3 (2012), 673–682, 10.1111/j.1360-0443.2011.03685.x.
8. Kasza, K.A., Hyland, A.J., Borland, R., et al. Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction 108:1 (2013), 193–202, 10.1111/j.1360-0443.2012.04009.x.
9. Fiore, M.C., Jaén, C.R., Baker, T.B., et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. May 2008, U.S. DHHS, Public Health Service, Rockville, MD.
10. Partos, T.R., Borland, R., Yong, H.H., Hyland, A., Cummings, K.M., The quitting rollercoaster: how recent quitting history affects future cessation outcomes (data from the International Tobacco Control 4-country cohort study). Nicotine Tob Res 15:9 (2013), 1578–1587, 10.1093/ntr/ntt025.
11. Cheong, Y., Yong, H.H., Borland, R., Does how you quit affect success? A comparison between abrupt and gradual methods using data from the International Tobacco Control Policy Evaluation Study. Nicotine Tob Res 9:8 (2007), 801–810, 10.1080/14622200701484961.
12. Kotz, D., Brown, J., West, R., ‘Real-world’ effectiveness of smoking cessation treatments: a population study. Addiction 109:3 (2014), 491–499, 10.1111/add.12429.
13. Ferguson, S.G., Brown, J., Frandsen, M., West, R., Associations between use of pharmacological aids in a smoking cessation attempt and subsequent quitting activity: a population study. Addiction 110:3 (2015), 513–518, 10.1111/add.12795.
14. Tonnesen, P., Norregaard, J., Sawe, U., Simonsen, K., Recycling with nicotine patches in smoking cessation. Addiction 88:4 (1993), 533–539, 10.1111/j.1360-0443.1993.tb02060.x.
15. Tonnesen, P., Mikkelsen, K., Norregaard, J., Jorgensen, S., Recycling of hard-core smokers with nicotine nasal spray. Eur Respir J 9:8 (1996), 1619–1623, 10.1183/09031936.96.09081619.
16. Gourlay, S.G., Forbes, A., Marriner, T., Pethica, D., McNeil, J.J., Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers. BMJ 311:7001 (1995), 363–366, 10.1136/bmj.311.7001.363.
17. Shiffman, S., Dresler, C.M., Rohay, J.M., Successful treatment with a nicotine lozenge of smokers with prior failure in pharmacological therapy. Addiction 99:1 (2004), 83–92, 10.1111/j.1360-0443.2004.00576.x.
18. Gonzales, D., Hajek, P., Pliamm, L., et al. Retreatment with varenicline for smoking cessation in smokers who have previously taken varenicline: a randomized, placebo-controlled trial. Clin Pharmacol Ther 96:3 (2014), 390–396, 10.1038/clpt.2014.124.
19. Gonzales, D.H., Nides, M.A., Ferry, L.H., et al. Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: a randomized placebo-controlled study. Clin Pharmacol Ther 69:6 (2001), 438–444, 10.1067/mcp.2001.115750.
20. Durcan, M.J., White, J., Jorenby, D.E., et al. Impact of prior nicotine replacement therapy on smoking cessation efficacy. Am J Health Behav 26:3 (2002), 213–220, 10.5993/AJHB.26.3.6.
21. Hughes, J.R., An updated algorithm for choosing among smoking cessation treatments. J Subst Abuse Treat 45:2 (2013), 215–221, 10.1016/j.jsat.2013.01.011.
22. Hughes, J., An algorithm for choosing among smoking cessation treatments. J Subst Abuse Treat 34:4 (2008), 426–432, 10.1016/j.jsat.2007.07.007.
23. Cropsey, K.L., Jardin, B.F., Burkholder, G.A., Clark, C.B., Raper, J.L., Saag, M.S., An algorithm approach to determining smoking cessation treatment for persons living with HIV/AIDS: results of a pilot trial. J Acquir Immune Defic Syndr 69:3 (2015), 291–298, 10.1097/QAI.0000000000000579.
24. Bader, P., McDonald, P., Selby, P., An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts. Tob Control 18:1 (2009), 34–42, 10.1136/tc.2008.025635.
25. Thompson, M.E., Fong, G.T., Hammond, D., et al. Methods of the International Tobacco Control (ITC) Four Country Survey. Tob Control 15:suppl 3 (2006), iii12–iii18, 10.1136/tc.2005.013870.
26. Heatherton, T., Kozlowski, L., Frecker, R.C., Rickert, W., Robinson, J., Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 84:7 (1989), 791–799, 10.1111/j.1360-0443.1989.tb03059.x.
27. Lei, H., Nahum-Shani, I., Lynch, K., Oslin, D., Murphy, S.A., “SMART” design for building individualized treatment sequences. Annu Rev Clin Psychol 8 (2012), 21–48, 10.1146/annurev-clinpsy-032511-143152.
28. SRNT, Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 4:2 (2002), 149–159, 10.1080/14622200210123581.
29. Hughes, J.R., Keely, J.P., Niaura, R.S., Ossip-Klein, D.J., Richmond, R.L., Swan, G.E., Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 5:1 (2003), 13–25, 10.1080/1462220031000070552.
30. Shiffman, S., Use of more nicotine lozenges leads to better success in quitting smoking. Addiction 102:5 (2007), 809–814, 10.1111/j.1360-0443.2007.01791.x.
31. Balmford, J., Borland, R., Hammond, D., Cummings, K.M., Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. Nicotine Tob Res 13:2 (2011), 94–102, 10.1093/ntr/ntq215.
32. Heckman, B.W., Mathew, A.R., Carpenter, M.J., Treatment burden and treatment fatigue as barriers to health. Curr Opin Psychol 5 (2015), 31–36, 10.1016/j.copsyc.2015.03.004.
33. Chen, L.S., Bloom, A.J., Baker, T.B., et al. Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6). Addiction 109:1 (2014), 128–137, 10.1111/add.12353.
34. Bergen, A.W., Javitz, H.S., Krasnow, R., et al. Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. Pharmacogenet Genomics 23:2 (2013), 94–103, 10.1097/FPC.0b013e32835cdabd.